Betamethasone valerate aerosol in asthmatic patients receiving long-term oral steroid therapy: double-blind controlled trial and follow-up of patients for 20 months.
D000284:Administration, Oral; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003366:Cosyntropin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013256:Steroids / Q000008:administration & dosage
D000336:Aerosols; D013256:Steroids; D003366:Cosyntropin; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D001624:Betamethasone Valerate; D011241:Prednisone